Jaguar Health Inc (NASDAQ: JAGX) shares are trading higher by 12.9% to $0.16 during Monday's session after the company was granted orphan drug designation by the European Medicines agency for microvillus disease.
What Else?
Napo Pharmaceuticals, Inc. ("Napo"), the wholly-owned subsidiary of Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the activation by the U.S. Food and
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.